Submission Details
| 510(k) Number | K213793 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 06, 2021 |
| Decision Date | April 01, 2022 |
| Days to Decision | 116 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K213793 is an FDA 510(k) clearance for the EMPOWR Revision Knee, a Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer (Class II — Special Controls, product code JWH), submitted by Encore Medical, L.P. (Austin, US). The FDA issued a Cleared decision on April 1, 2022, 116 days after receiving the submission on December 6, 2021. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3560.
| 510(k) Number | K213793 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 06, 2021 |
| Decision Date | April 01, 2022 |
| Days to Decision | 116 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | JWH — Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3560 |